Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition

Rheumatology (Oxford). 2016 Jun;55(6):1143-5. doi: 10.1093/rheumatology/kew063. Epub 2016 Apr 11.

Authors

Rob R H van den Brom¹, Wayel H Abdulahad², Abraham Rutgers², Bart-Jan Kroesen³, Caroline Roozendaal³, Derk Jan A de Groot¹, Carolien P Schröder¹, Geke A P Hospers¹, Elisabeth Brouwer⁴

Affiliations

¹ Department of Medical Oncology.
² Department of Rheumatology and Clinical Immunology.
³ Department of Medical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
⁴ Department of Rheumatology and Clinical Immunology e.brouwer@umcg.nl.

PMID: 27069016
DOI: 10.1093/rheumatology/kew063

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects
Antineoplastic Agents, Immunological / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Female
Granulomatosis with Polyangiitis / chemically induced*
Humans
Ipilimumab / adverse effects
Melanoma / drug therapy
Middle Aged

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Ipilimumab
pembrolizumab